Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
| Autor: | Gonem, Sherif, Berair, Rachid, Singapuri, Amisha, Hartley, Ruth, Laurencin, Marie F M, Bacher, Gerald, Holzhauer, Björn, Bourne, Michelle, Mistry, Vijay, Pavord, Ian D, Mansur, Adel H, Wardlaw, Andrew J, Siddiqui, Salman H, Kay, Richard A, Brightling, Christopher E |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine September 2016 4(9):699-707 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|